InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
6
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+39.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Mcpeak Merrill A. Director active across 4 companies, notably Research Solutions, Inc.. Aggregated, 17 disclosures have been logged. Breakdown: 6 buys · 0 sell. Total volume traded: €2.4m. Activity tracked since 7 June 2021. The latest transaction was filed on 12 November 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mcpeak Merrill A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
75,000 shares@ US$0.7016.4% of flowCommon StockSEC:0001104659-25-120763:0
75,000 shares@ US$1.1031.2% of flowCommon StockSEC:0001104659-25-060722:0
50,000 shares@ US$1.0529.3% of flowCommon StockSEC:0001104659-25-056481:0
250,000 shares@ US$9.1580.3% of flowCommon StockSEC:0001104659-24-025684:0
Canonical exit: 20 May 2024 (T+90)
10,000 shares@ US$5.5610.0% of flowCommon StockSEC:0001104659-23-101954:0
Canonical exit: 17 Dec 2023 (T+90)
50,000 shares@ US$1.1544.3% of flowCommon StockSEC:0001104659-23-004393:0
10,000 shares@ US$6.152.2% of flowCommon StockSEC:0001104659-22-129516:0
Canonical exit: 21 Mar 2023 (T+90)
10,000 shares@ US$6.312.3% of flowCommon StockSEC:0001104659-22-123244:0
Canonical exit: 27 Feb 2023 (T+90)
10,000 shares@ US$6.182.3% of flowCommon StockSEC:0001104659-22-122555:0
Canonical exit: 26 Feb 2023 (T+90)
40,000 shares@ US$5.658.6% of flowCommon StockSEC:0001104659-22-094430:0
50,000 shares@ US$1.1942.9% of flowCommon StockSEC:0001104659-22-088882:0
10,000 shares@ US$6.84100.0% of flowCommon StockSEC:0001104659-22-067763:0
Canonical exit: 29 Aug 2022 (T+90)
7,500 shares@ US$1.252.8% of flowCommon StockSEC:0001104659-21-079631:0
400,000 sharesCommon StockSEC:0001213900-16-010532:0
914 sharesCommon StockSEC:0001127602-16-037277:0
457 sharesCommon StockSEC:0001127602-16-037277:1
106,250 sharesCommon StockSEC:0001213900-16-009940:0
17 of 17 declarations
About Mcpeak Merrill A
MCPEAK MERRILL A is a declarant with 17 filings in total. In the 17 recent sampled filings between 2016-01-06 and 2025-12-12, the transactions are mainly option exercises, with EUR 2417085 of buys and EUR 0 of sells, and the person is listed as Director at Iovance Biotherapeutics, INC., Research Solutions, Inc., LILIS ENERGY, INC., and Aerojet Rocketdyne Holdings, INC.
